Gilead Nears Completion of CymaBay Acquisition After Waiting Period Expires
Gilead Sciences (NASDAQ: GILD) has moved one step closer to finalizing its cash tender offer...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
Gilead Sciences (NASDAQ: GILD) has moved one step closer to finalizing its cash tender offer...